Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Cyntellect
AddedFeb 15, 2024
UpdatedJun 18, 2026
Cyntellect

Cyntellect

Acquired

Cyntellect, Inc. offers advanced biomedical tech for cell analysis, purification, and live-cell imaging across the US.

HQ
San Diego, CA, US
Founded
1997
Overview
Compare
Fundraising
Employees

Cyntellect, Inc. offers advanced biomedical technology products focused on cell analysis, purification, and live-cell imaging. Their automated systems for laser-based cell manipulation serve customers throughout the United States, aiming to enhance biomedical research and clinical applications.

Cyntellect has made significant strides in the biomedical field, providing cutting-edge solutions that improve the accuracy and efficiency of cell processing. Their technologies have been widely adopted in research institutions and clinical settings, contributing to advancements in cell biology and medical treatments.

Cyntellect - Similar Companies

LumaCyte logo

LumaCyte

lumacyte.com

CytoRecovery logo

CytoRecovery

cytorecovery.com

Cellomics Technology logo

Cellomics Technology

cellomicstech.com

RhinoCyte logo

RhinoCyte

rhinocyte.com

Cytocybernetics logo

Cytocybernetics

Sentien Biotechnologies logo

Sentien Biotechnologies

CytoMag logo

CytoMag

Lyncean Technologies logo

Lyncean Technologies

lynceantech.com

Cytonics logo

Cytonics

cytonics.com

Celldom logo

Celldom

celldom.com

Centrillion Technologies logo

Centrillion Technologies

Launchcyte logo

Launchcyte

launchcyte.com

jCyte logo

jCyte

jcyte.com

Cellia Science logo

Cellia Science

celliasci.com

QuantumCyte logo

QuantumCyte

quantumcyte.com

Cyntellect - Quick Facts

Who are Cyntellect's competitors?

Companies similar to Cyntellect include LumaCyte, CytoRecovery, Cellomics Technology and RhinoCyte.

When was Cyntellect founded?

Cyntellect was founded in 1997.

Where is Cyntellect's headquarters located?

Cyntellect's headquarters is located in San Diego, CA, US.

When was Cyntellect's last funding round?

Cyntellect's most recent funding round was for $9M (USD) in July 2010.

How much has Cyntellect raised to-date?

As of Jul 16, 2010, Cyntellect has raised a total of $42.6M (USD).

Cyntellect - Classification

Industry
  • Hardware
Ownership
  • Private
Technology
  • Automation
  • Robotics
Geographic Exposure
  • United States
Revenue
  • Software
  • Transactional
Customer
  • Enterprise
  • Government
Main Product
  • Biotech
  • Cell Analysis
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 15 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 541000Professional, Scientific, and Technical Services
  • 623000Nursing and Residential Care Facilities
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research